An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers

Moran Elishmereni, Yuri Kheifetz, Henrik Søndergaard, Rune Viig Overgaard, Zvia Agur. An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers. PLoS Computational Biology, 7(9), 2011. [doi]

Abstract

Abstract is missing.